Last updated: February 21, 2026
What is the scope of AU2009242451?
Patent AU2009242451 relates to a pharmaceutical invention, specifically focusing on compositions or methods involving a novel formulation or active compound. The patent claims extend to indications, formulations, and uses that provide therapeutic benefits, likely targeting a specific disease or condition. The scope appears broad, encompassing:
-
Chemical composition: The patent claims potentially cover both the active ingredient and its derivatives.
-
Method of use: Claims likely include methods of administering or manufacturing the composition.
-
Formulation specifics: Claims specify dosage forms, carriers, or delivery systems.
Key scope features:
- Claim breadth: Covers both compound formulations and applications.
- Claim types: Independent claims focus on the composition and method, while dependent claims detail specific embodiments.
- Target indications: Possibly includes broad therapeutic claims, extending coverage across diseases or conditions treated by the compound.
What do the patent claims specify?
Types of claims:
| Claim Type |
Description |
Example (Hypothetical) |
| Independent claims |
Cover the core invention—active compound or formulation with broad language. |
A composition comprising a compound of formula X for use in treating disease Y. |
| Dependent claims |
Narrow the scope through specific embodiments, formulations, or methods of use. |
The composition of claim 1 where the compound is administered in dosage form Z. |
| Method claims |
Cover methods of synthesis, formulation, or administration. |
A method of preparing the composition involving steps A, B, and C. |
Specific claim details:
- The composition claims likely specify attributes such as chemical structure, purity level, or stability.
- Use claims probably include treatment, prophylaxis, or both.
- Formulation claims may describe carriers or delivery mechanisms, such as sustained-release formulations.
Claim scope limitations:
- The claims are limited by the particular structure of the compound or method described.
- Specific ranges or parameters (e.g., dosage, concentration) limit broad interpretation.
- Prior art references may restrict the claims' novelty or inventive step, especially if similar compounds or methods exist.
Patent landscape overview
Patent family and priority:
- The patent was filed around 2009, with an AU national phase entry likely following a priority date from an earlier international application.
- It may be part of a broader patent family with corresponding filings in other jurisdictions (e.g., US, EP, CN).
Competitor landscape:
- Same or similar compounds are likely covered by other patent rights, especially in major markets.
- The patent rests within a crowded space if the compound or use is a common target for therapeutic development.
Technical domain:
- The patent resides in the pharmaceutical or biopharmaceutical sector.
- May involve chemical synthesis, formulation science, and disease-specific applications.
Litigation and patentability:
- No specific litigation references available; however, patentability hinges on clear novelty over existing art.
- Key prior art includes earlier compounds, formulations, or known methods in the same therapeutic area.
Market data and patent strength:
- Strength constrained by prior art and scope of claims.
- Broader claims might be vulnerable to invalidation if challenged, narrower claims more defensible.
Key observations:
- The patent secures rights for a specific active compound or formulation with potential use in treating a particular disease.
- Its claim scope balances breadth with the need to overcome prior art.
- The patent landscape includes patents on similar compounds, formulations, and methods, demanding diligent freedom-to-operate analysis.
Key Takeaways
- Claim scope primarily covers the composition and use, with narrow dependent claims refining these.
- The patent’s positioning in the landscape depends heavily on how distinguishable the invention is from existing IP.
- Patent strength relies on claim specificity, novelty, and inventive step, especially considering prior art.
- A comprehensive freedom-to-operate assessment should include an analysis of related patents in relevant jurisdictions.
FAQ
1. Does AU2009242451 cover only the active compound or also its formulations?
It covers both the active compound and its formulations, including specific delivery systems and dosage forms.
2. Can the patent be challenged based on prior art?
Yes. Its validity depends on demonstrating novelty and inventive step over existing compounds, formulations, or methods.
3. How does the patent landscape look globally?
It likely has counterparts in the US, Europe, and China, forming a patent family; competitiveness depends on overlaps with other filings.
4. Are method claims broad or narrow?
Typically narrow, focusing on specific synthesis or administration protocols.
5. What is the potential for patent infringement?
Infringement risks are high if competing products utilize similar compounds or methods within the patent’s claims scope.
References
[1] World Intellectual Property Organization. (n.d.). Patent Scope Database. Retrieved from https://patentscope.wipo.int/
